Literature DB >> 1319324

Stimulatory effect of vanadate on 3',5'-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads.

H Ueki1, R Okuhama, M Sera, T Inoue, N Tominaga, T Morita.   

Abstract

When isolated rat fat pads were incubated with vanadate, the low Michaelis-Menten constant (Km) cAMP phosphodiesterase (PDE) activity in the microsomal fraction was increased in a time- and dose-dependent manner with vanadate. 3',5'-Cyclic GMP inhibited the vanadate-stimulated PDE activity with similar profile to the insulin-stimulated one. The stimulatory effect of vanadate was inhibited by inhibitors of tyrosine kinases such as amiloride, biochanin A, and genistein to various extents. Vanadate and insulin both showed the full effect in the absence of either K+, N+, or Ca2+ in the medium, while preincubation of the fat pads with a chelator of intracellular Ca2+ inhibited the vanadate action in a dose-dependent manner. The insulin action was not inhibited by it at tested concentrations. These results suggest that the vanadate action, in contrast to the insulin one, is dependent on the intracellular level of Ca2+. Preincubation of the fat pads with inhibitors of protein kinase C such as 1-(5-isoquinoline sulfonyl)-2-methylpiperazine (H-7) and staurosporine inhibited, in part, the vanadate action but did not inhibit the insulin one. Furthermore, vanadate increased the protein kinase C activity in fat pads but insulin did not increase. H-7 and amiloride showed a significant inhibition of stimulation of protein kinase C activity by vanadate. These results suggest that vanadate stimulates, in part, the 3',5'-cyclic GMP-inhibited low Km cAMP PDE activity in the microsomal fraction of fat pads through the activation of tyrosine kinase and protein kinase C-mediated processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319324     DOI: 10.1210/endo.131.1.1319324

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase.

Authors:  R W Brownsey; G W Dong
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 2.  In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus.

Authors:  A B Goldfine; D C Simonson; F Folli; M E Patti; C R Kahn
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Inhibition of cyclic AMP dependent protein kinase by vanadyl sulfate.

Authors:  Kioumars A Jelveh; Rachel Zhande; Roger W Brownsey
Journal:  J Biol Inorg Chem       Date:  2006-02-28       Impact factor: 3.358

4.  A stable peroxovanadium compound with insulin-like action in human fat cells.

Authors:  J W Eriksson; P Lönnroth; B I Posner; A Shaver; C Wesslau; U P Smith
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.